71
An interesting one to keep an eye on as it provides a Canadian investment at a low cost that is near licensing with announced international expansion. However, always take caution because the facts are it does not have a license as yet; none of its product has been sold as yet through CGC’s CraftGrow channel; and its international expansion plans are just that – plans.
True Leaf Medicine Inc.
(CSE:MJ; OTC:TRLFF)
Share Price when featured:
Share Price (high) Sept 27:
That is an ROI of 101% since May 25.
Shares Outstanding: 69,845,287
Market Cap when featured: US$19.6M
Last Quarterly Revenue: US$241M
True Leaf has been mentioned regularly since 2016 in these pages (both editions) because at different times it has hit different strategies:
- They are in the animal care sector
- They have international sales
- They have stock listings in three countries (USA, Canada, Germany)
- They are a latter stage applicant for production license in Canada
- Impressive and increase sales
- Relatively low float.
- Crowd Funding Investment opportunity open to investors in the USA as well as Canada. For information on that financing opportunity just click HERE.
Let’s review how investing in these three sample companies may have played out.
What if you bought on the Canadian index by converting USD to CAD on purchase date and converted back to USD on sale date:
In this scenario, that ignores extra commissions and any tax implications, you can see how the overall ROI is different (yet impressive) in all three scenarios.